Definition and mathematical meaning
It is important to understand that the volume of distribution is not a real anatomical reservoir in the human body, but a purely mathematical model. The more actively drug molecules leave the bloodstream and pass into tissues, the lower their plasma concentration will be, and consequently, the higher the calculated $V_d$ value will turn out to be.
To calculate within a one-compartment pharmacokinetic model, the basic formula is used: $$V_d = \frac{Q}{C_p}$$ Where $Q$ denotes the total amount of the drug substance in the body, and $C_p$ is its current blood plasma concentration.
If a drug is administered intravenously, it is assumed that the dose ($D$) is distributed instantly. In this case, the calculation is based on the initial concentration ($C_0$) recorded immediately after administration: $V_d = \frac{D}{C_0}$.
Classification of compartments
Depending on the magnitude of $V_d$, one can predict which biological barriers a drug is capable of crossing:
- Low volume (about 3 L). Anatomically, it corresponds to the average plasma volume. High-molecular-weight compounds that are physically unable to leak through the capillary endothelium or penetrate inside blood cells remain in this space. A classic example of such a substance is heparin (its $V_d$ is about 3.6 L).
- Moderate volume (about 15 L). Reflects the total volume of extracellular fluid (vascular bed plus interstitium). It is characteristic of hydrophilic compounds. They easily cross the endothelium, but cell membranes remain an insurmountable barrier for them (they do not enter cells). Typical representatives are aminoglycosides (gentamicin, tobramycin).
- High volume (40–46 L). Corresponds to total body water volume. The drug freely penetrates all media, including intracellular fluid.
Clinical significance of the parameter
Understanding the localization of a drug determines its clinical efficacy. For example, drugs with a moderate $V_d$ that do not enter cells will be useless in treating intracellular infections. In addition, they do not cross the blood-brain barrier (BBB), making their use ineffective in bacterial meningitis.
Drugs with ultra-high $V_d$ values that significantly exceed real human physiological fluid volumes require special attention in medical practice. Such substances include:
- Digoxin (about 500 L);
- Tricyclic antidepressants, such as imipramine and amitriptyline (about 1600 L);
- Chloroquine (reaches 13,000 L).
Such figures mean that the drug practically does not linger in the blood, but is actively sequestered in tissues. This is of critical importance in toxicology: in case of poisoning with such drugs, the hemodialysis procedure is absolutely ineffective, since purifying the blood is pointless—the bulk of the toxin is hidden in the organs.
Factors affecting distribution
The $V_d$ parameter is not a strict constant and can vary. Its final value in a specific patient is influenced by:
- Biological sex;
- Patient age;
- Individual ratio of adipose tissue to body water volumes.
Briefly: answers to topical questions
Which groups of drug substances have a low volume of distribution (about 3 L)?
A low volume of distribution (about 3 L), corresponding to the average blood plasma volume, is characteristic of high-molecular-weight compounds.
They are predominantly localized in the vascular bed and do not cross the vascular endothelium or penetrate inside blood cells. An example is heparin, whose volume of distribution is about 3.6 L.
Which drugs are characterized by an ultra-high volume of distribution, significantly exceeding body fluid volumes?
An ultra-high volume of distribution, significantly exceeding the real volume of body fluids, is characteristic of drugs that are sequestered in peripheral tissues.
Such drugs include:
- Digoxin — volume of distribution of about 500 L.
- Tricyclic antidepressants — imipramine and amitriptyline (about 1050–1600 L).
- Chloroquine — volume of distribution of about 13,000 L.
Which physiological and pathological factors can alter a patient's volume of distribution for a drug?
The volume of distribution of a drug can change under the influence of a number of physiological factors and age-related changes.
This parameter is influenced by:
- Sex and age — determine the specific features of substance distribution.
- Body composition — the ratio of adipose tissue to body water.
- Protein levels — a decrease in plasma albumin levels (e.g., in the elderly) leads to an increase in the volume of distribution.
How is the volume of distribution parameter used to calculate drug doses in clinical practice?
The volume of distribution parameter is used in clinical practice to calculate the loading dose of a drug.
The loading dose is administered first to rapidly fill the volume of distribution and achieve the target steady-state concentration. The calculation is performed using the formula: $D_H = V_d \cdot C_{ss}$ where $D_H$ is the loading dose, $V_d$ is the volume of distribution, and $C_{ss}$ is the desired steady-state concentration. Also, the basic formula $V_d = D / C_0$ relates the administered dose and the initial concentration.
Which physicochemical properties of a drug molecule restrict its distribution exclusively to the vascular bed?
The distribution of a drug exclusively to the vascular bed is due to its high molecular weight and inability to cross the vascular endothelium. Such compounds also do not penetrate inside blood cells, so the substance is located predominantly in the vascular bed, mainly in the blood plasma.
Class and exam questions
What does it mean if the calculated Vd exceeds the actual total volume of all body fluids?
This indicates pronounced sequestration of the drug in peripheral tissues. As a result, the concentration of such a substance directly in the blood plasma remains extremely low.
Is it possible to save a patient with hemodialysis in chloroquine overdose?
No, hemodialysis will be ineffective. Chloroquine has a huge apparent volume of distribution (about 13,000 liters), so it is localized mainly in deep tissues rather than in the circulating blood.
Why are aminoglycosides not used to treat bacterial meningitis?
Aminoglycosides have a moderate volume of distribution. Being hydrophilic compounds, they cannot cross cell membranes, meaning they are unable to cross the blood-brain barrier.
What else to study on this topic
- One-compartment pharmacokinetic model
- Physiological barriers: vascular endothelium and blood-brain barrier (BBB)
- Impact of hydrophilicity on molecule distribution
- Mechanisms of drug sequestration in tissues
- Influence of the adipose tissue-to-water ratio on pharmacokinetics
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Volume of distribution" and 5,304 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in "General Pharmacology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.